Skip to main content
SpringerLink
Log in

Is there a relationship between becaplermin use and cancer?

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.Communication about an Ongoing Safety Review Regranex (becaplermin). Media Release: 27 Mar 2008. Available from: URL: http://www.fda.gov

  2. BioMimetic Therapeutics Inc.BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review. Media Release: 28 Mar 2008. Available from: URL: http://www.biomimetics.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Is there a relationship between becaplermin use and cancer?. React. Wkly. 1196, 3 (2008). https://doi.org/10.2165/00128415-200811960-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811960-00006

Keywords

Search

Navigation